Literature DB >> 25174034

Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Lindsay M Morton1, Susan L Slager1, James R Cerhan1, Sophia S Wang1, Claire M Vajdic1, Christine F Skibola1, Paige M Bracci1, Silvia de Sanjosé1, Karin E Smedby1, Brian C H Chiu1, Yawei Zhang1, Sam M Mbulaiteye1, Alain Monnereau1, Jennifer J Turner1, Jacqueline Clavel1, Hans-Olov Adami1, Ellen T Chang1, Bengt Glimelius1, Henrik Hjalgrim1, Mads Melbye1, Paolo Crosignani1, Simonetta di Lollo1, Lucia Miligi1, Oriana Nanni1, Valerio Ramazzotti1, Stefania Rodella1, Adele Seniori Costantini1, Emanuele Stagnaro1, Rosario Tumino1, Carla Vindigni1, Paolo Vineis1, Nikolaus Becker1, Yolanda Benavente1, Paolo Boffetta1, Paul Brennan1, Pierluigi Cocco1, Lenka Foretova1, Marc Maynadié1, Alexandra Nieters1, Anthony Staines1, Joanne S Colt1, Wendy Cozen1, Scott Davis1, Anneclaire J de Roos1, Patricia Hartge1, Nathaniel Rothman1, Richard K Severson1, Elizabeth A Holly1, Timothy G Call1, Andrew L Feldman1, Thomas M Habermann1, Mark Liebow1, Aaron Blair1, Kenneth P Cantor1, Eleanor V Kane1, Tracy Lightfoot1, Eve Roman1, Alex Smith1, Angela Brooks-Wilson1, Joseph M Connors1, Randy D Gascoyne1, John J Spinelli1, Bruce K Armstrong1, Anne Kricker1, Theodore R Holford1, Qing Lan1, Tongzhang Zheng1, Laurent Orsi1, Luigino Dal Maso1, Silvia Franceschi1, Carlo La Vecchia1, Eva Negri1, Diego Serraino1, Leslie Bernstein1, Alexandra Levine1, Jonathan W Friedberg1, Jennifer L Kelly1, Sonja I Berndt1, Brenda M Birmann1, Christina A Clarke1, Christopher R Flowers1, James M Foran1, Marshall E Kadin1, Ora Paltiel1, Dennis D Weisenburger1, Martha S Linet1, Joshua N Sampson1.   

Abstract

BACKGROUND: Non-Hodgkin lymphoma (NHL) comprises biologically and clinically heterogeneous subtypes. Previously, study size has limited the ability to compare and contrast the risk factor profiles among these heterogeneous subtypes.
METHODS: We pooled individual-level data from 17 471 NHL cases and 23 096 controls in 20 case-control studies from the International Lymphoma Epidemiology Consortium (InterLymph). We estimated the associations, measured as odds ratios, between each of 11 NHL subtypes and self-reported medical history, family history of hematologic malignancy, lifestyle factors, and occupation. We then assessed the heterogeneity of associations by evaluating the variability (Q value) of the estimated odds ratios for a given exposure among subtypes. Finally, we organized the subtypes into a hierarchical tree to identify groups that had similar risk factor profiles. Statistical significance of tree partitions was estimated by permutation-based P values (P NODE).
RESULTS: Risks differed statistically significantly among NHL subtypes for medical history factors (autoimmune diseases, hepatitis C virus seropositivity, eczema, and blood transfusion), family history of leukemia and multiple myeloma, alcohol consumption, cigarette smoking, and certain occupations, whereas generally homogeneous risks among subtypes were observed for family history of NHL, recreational sun exposure, hay fever, allergy, and socioeconomic status. Overall, the greatest difference in risk factors occurred between T-cell and B-cell lymphomas (P NODE < 1.0×10(-4)), with increased risks generally restricted to T-cell lymphomas for eczema, T-cell-activating autoimmune diseases, family history of multiple myeloma, and occupation as a painter. We further observed substantial heterogeneity among B-cell lymphomas (P NODE < 1.0×10(-4)). Increased risks for B-cell-activating autoimmune disease and hepatitis C virus seropositivity and decreased risks for alcohol consumption and occupation as a teacher generally were restricted to marginal zone lymphoma, Burkitt/Burkitt-like lymphoma/leukemia, diffuse large B-cell lymphoma, and/or lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
CONCLUSIONS: Using a novel approach to investigate etiologic heterogeneity among NHL subtypes, we identified risk factors that were common among subtypes as well as risk factors that appeared to be distinct among individual or a few subtypes, suggesting both subtype-specific and shared underlying mechanisms. Further research is needed to test putative mechanisms, investigate other risk factors (eg, other infections, environmental exposures, and diet), and evaluate potential joint effects with genetic susceptibility. Published by Oxford University Press 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25174034      PMCID: PMC4155467          DOI: 10.1093/jncimonographs/lgu013

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  55 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

2.  Reliability of self-reported family history of cancer in a large case-control study of lymphoma.

Authors:  Ellen T Chang; Karin Ekström Smedby; Henrik Hjalgrim; Bengt Glimelius; Hans-Olov Adami
Journal:  J Natl Cancer Inst       Date:  2006-01-04       Impact factor: 13.506

Review 3.  Recent progress in the understanding of B-cell functions in autoimmunity.

Authors:  N Porakishvili; R Mageed; C Jamin; J O Pers; N Kulikova; Y Renaudineau; P M Lydyard; P Youinou
Journal:  Scand J Immunol       Date:  2001 Jul-Aug       Impact factor: 3.487

4.  Medical history, lifestyle, family history, and occupational risk factors for adult acute lymphocytic leukemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Christine F Skibola; Susan L Slager; Sonja I Berndt; Tracy Lightfoot; Joshua N Sampson; Lindsay M Morton; Dennis D Weisenburger
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

Review 5.  Double-hit B-cell lymphomas.

Authors:  Sietse M Aukema; Reiner Siebert; Ed Schuuring; Gustaaf W van Imhoff; Hanneke C Kluin-Nelemans; Evert-Jan Boerma; Philip M Kluin
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

6.  Menstrual and reproductive factors, and hormonal contraception use: associations with non-Hodgkin lymphoma in a pooled analysis of InterLymph case-control studies.

Authors:  E V Kane; E Roman; N Becker; L Bernstein; P Boffetta; P M Bracci; J R Cerhan; B C-H Chiu; P Cocco; L Costas; L Foretova; E A Holly; C La Vecchia; K Matsuo; M Maynadie; S Sanjose; J J Spinelli; A Staines; R Talamini; S S Wang; Y Zhang; T Zheng; A Kricker
Journal:  Ann Oncol       Date:  2012-07-10       Impact factor: 32.976

7.  Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.

Authors:  Eleanor V Willett; Lindsay M Morton; Patricia Hartge; Nikolaus Becker; Leslie Bernstein; Paolo Boffetta; Paige Bracci; James Cerhan; Brian C-H Chiu; Pierluigi Cocco; Luigino Dal Maso; Scott Davis; Silvia De Sanjose; Karin Ekstrom Smedby; Maria Grazia Ennas; Lenka Foretova; Elizabeth A Holly; Carlo La Vecchia; Keitaro Matsuo; Marc Maynadie; Mads Melbye; Eva Negri; Alexandra Nieters; Richard Severson; Susan L Slager; John J Spinelli; Anthony Staines; Renato Talamini; Martine Vornanen; Dennis D Weisenburger; Eve Roman
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

8.  Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma.

Authors:  Yawei Zhang; Silvia De Sanjose; Paige M Bracci; Lindsay M Morton; Rong Wang; Paul Brennan; Patricia Hartge; Paolo Boffetta; Nikolaus Becker; Marc Maynadie; Lenka Foretova; Pierluigi Cocco; Anthony Staines; Theodore Holford; Elizabeth A Holly; Alexandra Nieters; Yolanda Benavente; Leslie Bernstein; Shelia Hoar Zahm; Tongzhang Zheng
Journal:  Am J Epidemiol       Date:  2008-04-11       Impact factor: 4.897

9.  AIDS-related cancer and severity of immunosuppression in persons with AIDS.

Authors:  Robert J Biggar; Anil K Chaturvedi; James J Goedert; Eric A Engels
Journal:  J Natl Cancer Inst       Date:  2007-06-12       Impact factor: 13.506

10.  Risk of lymphoma subtypes after solid organ transplantation in the United States.

Authors:  C A Clarke; L M Morton; C Lynch; R M Pfeiffer; E C Hall; T M Gibson; D D Weisenburger; O Martínez-Maza; S K Hussain; J Yang; E T Chang; E A Engels
Journal:  Br J Cancer       Date:  2013-06-11       Impact factor: 9.075

View more
  96 in total

Review 1.  Familial predisposition and genetic risk factors for lymphoma.

Authors:  James R Cerhan; Susan L Slager
Journal:  Blood       Date:  2015-09-24       Impact factor: 22.113

2.  Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.

Authors:  Nadia Howlader; Lindsay M Morton; Eric J Feuer; Caroline Besson; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-15       Impact factor: 4.254

3.  Identifying risk factors for B-cell lymphoma.

Authors:  Christopher R Flowers; Christine F Skibola
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

4.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Subsequent Neoplasms Working Group Report.

Authors:  Lindsay M Morton; Wael Saber; K Scott Baker; A John Barrett; Smita Bhatia; Eric A Engels; Shahinaz M Gadalla; David E Kleiner; Steven Pavletic; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-12       Impact factor: 5.742

5.  Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.

Authors:  Megan M Herr; Sara J Schonfeld; Graça M Dores; Diana R Withrow; Margaret A Tucker; Rochelle E Curtis; Lindsay M Morton
Journal:  J Natl Cancer Inst       Date:  2018-11-01       Impact factor: 13.506

6.  A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.

Authors:  Yu-Han Chiu; Kimberly A Bertrand; Shumin Zhang; Francine Laden; Mara M Epstein; Bernard A Rosner; Stephanie Chiuve; Hannia Campos; Edward L Giovannucci; Jorge E Chavarro; Brenda M Birmann
Journal:  Int J Cancer       Date:  2018-08-10       Impact factor: 7.396

7.  Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.

Authors:  Laura Costas; Leila Lujan-Barroso; Yolanda Benavente; Naomi E Allen; Pilar Amiano; Eva Ardanaz; Caroline Besson; Heiner Boeing; Bas Bueno-de-Mesquita; Iris Cervenka; Renée T Fortner; Agnès Fournier; Marc Gunter; Sophia Harlid; José María Huerta; Mats Jerkeman; Karin Jirström; Rudolf Kaaks; Anna Karakatsani; Kay-Tee Khaw; Anastasia Kotanidou; Eiliv Lund; Giovanna Masala; Amalia Mattiello; Beatrice Melin; Virginia Menéndez; Neil Murphy; Alexandra Nieters; Kim Overvad; Elio Riboli; Carlotta Sacerdote; Maria-Jose Sánchez; Julie A Schmidt; Sabina Sieri; Anne Tjønneland; Antonia Trichopoulou; Rosario Tumino; Roel Vermeulen; Elisabete Weiderpass; Silvia de Sanjosé; Antonio Agudo; Delphine Casabonne
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

8.  Allergies and the Subsequent Risk of Cancer among Elderly Adults in the United States.

Authors:  Monica D'Arcy; Donna R Rivera; Andrew Grothen; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

9.  Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Authors:  Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-26       Impact factor: 4.254

10.  Polycyclic aromatic hydrocarbons: determinants of residential carpet dust levels and risk of non-Hodgkin lymphoma.

Authors:  Curt T DellaValle; Nicole C Deziel; Rena R Jones; Joanne S Colt; Anneclaire J De Roos; James R Cerhan; Wendy Cozen; Richard K Severson; Abigail R Flory; Lindsay M Morton; Mary H Ward
Journal:  Cancer Causes Control       Date:  2015-11-16       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.